Designed, implemented, documented, and defended intercompany prices for a multinational consumer products company based in the US, including the appropriate royalty for the use of intangible property, tangible property transfers, and compensation for intercompany services. Also provided ongoing coordination of advice with international tax support provided by outside advisors.
Drug pricing rules and tariffs reshape transfer pricing for IP
In the article “Drug Pricing Rules and Tariffs Reshape Transfer Pricing for IP,” published in Bloomberg Tax, CRA’s Transfer Pricing experts Robin Hart and ...